Kanbi  Pharma  Teknoloji  Limite
2192215-81-7 ritlecitinib tosylate

2192215-81-7 ritlecitinib tosylate

CAS: 2192215-81-7
MF: C22H27N5O4S
MW: 457.55
Einecs: 201-058-9
MDL Non.:

Voye rechèch
Dekri teren

Pwopriyete
fòme solid
Koulè blan nan koupe-blan

 

Aplikasyon:

Ritlecitinib tosylate se yon inibitè selektif JAK3, chimikman yo te rele 4- methylbenzenesulfonate rituxitinib. Li fè pati klas inibitè JAK la, sitou itilize pou trete enflamasyon ak maladi auto -immunes, espesyalman alopesi areata.
 

Sinonim:

Ritlecitinib tosylate

Ritlecitinib toslate

Pf -06651600 Tosylate

Litfulo

2192215-81-7

Ritlecitinib (tosylate)

Litfulo

Chembl5314649

Hy -100754 C

CS -0188778

D11970

1- [(2s, 5r) -2- methyl -5- (7h-pirrolo [2, 3- d] pyrimidin -4- ylamino) Piperidin {{} 4- methylbenzenesulfonate (1: 1)

1- {(2s, 5r) -2- methyl -5- [(7h-pirrolo [2, 3- d] Pyrim idin -4- yl) amino] piperidin -1- yl} prop -2- en -1- yon sèl 4 methylbenzene -1- asid sulfonic

4- methylbenzene -1- sulfonic asid --1- {(2s, 5r) -2- methyl -5- [(7h-pirrolo [2, 3- d] pyr imidin -4- yl) amino] piperidin -1- yl} prop -2- en -1- yon sèl (1/1)

4- methylbenzenesulfonic asid; 1- [(2s, 5r) -2- methyl -5- (7h-pirrolo [2, 3- d] pyrimidin -4- ylamino) Piperidin -1-}} {

 

Baj popilè: 2192215-81-7 ritlecitinib tosylate, Lachin 2192215-81-7 Ritlecitinib Tosylate Manifaktirè, Swèd

Inquiry
goTop

(0/10)

clearall